Parkinson's Disease Biomarker Innovation and Advancement Program supports teams developing fluid- and imaging-based biomarkers for clinical implementation and broader use in Parkinson's research.
The Parkinson's Foundation Impact Awards fund bold research to advance understanding of Parkinson’s disease biology or accelerate new interventions.
Biomarker Accelerator Grant Program supports researchers translating and validating existing PSP biomarkers for research and clinical use, aiming to improve diagnosis, monitoring and treatment-response assessment.
Biomarker Accelerator Program supports researchers pursuing biomarker discoveries for progressive supranuclear palsy to accelerate diagnosis, treatment, research, or clinical care.
The Michael J. Fox Foundation's BFDN grant supports early career researchers whose neurodegenerative disease projects were disrupted by changes in U.S. federal funding.
The Parkinson’s Foundation Research Centers grant funds interdisciplinary teams to advance innovative, collaborative research into the causes, mechanisms, and treatment of Parkinson’s disease.